Drug Type Monoclonal antibody |
Synonyms a humanized, immunoglobulin G subtype 4 anti-Amphiregulin monoclonal antibody |
Target |
Mechanism AREG modulators(Amphiregulin ligand modulators), Immunomodulators |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
RegulationOrphan Drug (US) |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Idiopathic Pulmonary Fibrosis | Preclinical | AU | 14 Oct 2021 |